Sahar Feizollahi Ashkar

Title: **Sahar Feizollahi Ashkar: Innovator in Pharmaceutical Compositions for Fungal Infections**

Introduction

Sahar Feizollahi Ashkar, located in Bromma, Sweden, is a notable inventor in the pharmaceutical industry. With a remarkable portfolio of two patents, his contributions are crucial in the fight against nail diseases, particularly onychomycosis.

Latest Patents

Sahar's latest patents focus on pharmaceutical compositions designed for the treatment of fungal infections. These compositions are suitable for topical application to nails and include a urea-based component, a diol component such as propylene glycol, an organic acid component like lactic acid, and a triol component such as glycerol. Furthermore, these patents elaborate on methods to enhance the storage stability of the pharmaceutical composition by incorporating a triol component prior to storage.

Career Highlights

As part of Moberg Pharma AB, Sahar has played a significant role in developing innovative solutions that cater to pressing medical needs. His expertise in pharmaceutical sciences has contributed to advancements in drug formulation and patient care.

Collaborations

Throughout his career, Sahar has collaborated with esteemed colleagues, including Ewa Karlsson and Peter Kaufmann. These partnerships have fostered a collaborative environment, facilitating the exchange of ideas that ultimately enhance the development of new therapeutic compositions.

Conclusion

Sahar Feizollahi Ashkar stands out as an influential inventor in the realm of pharmaceuticals. With his innovative patents focusing on fungal infections, he continues to make strides in improving treatment options for patients suffering from nail diseases. His work at Moberg Pharma AB, alongside talented collaborators, showcases the power of innovation in addressing health challenges.